Submitted by Anonymous (not verified) on 25 July 2025 - 9:53
Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 30, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mysimba, naltrexone,bupropion, Date of authorisation: 26/03/2015, Revision: 30, Status: Authorised